Quantcast

Latest rheumatoid arthritis Stories

2014-06-12 00:22:01

Both doses of investigational drug sarilumab met all three co-primary endpoints PARIS and TARRYTOWN, N.Y., June 12, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today presented positive results from a phase 3 trial of investigational drug sarilumab in rheumatoid arthritis (RA) patients who were inadequate responders to methotrexate (MTX) therapy. New data presented at the meeting showed that sarilumab increased major clinical...

2014-06-11 04:21:56

- Findings Show Positive Association Between Adherence and Anti-TNF Therapy Compared to Conventional Therapy PARIS, June 11, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases (IMIDs), adherence to treatment was generally higher in patients being treated with TNF inhibitors compared to patients treated with conventional therapy. Furthermore, patients who were...

2014-06-10 23:13:54

Achieve is conducting a multicenter, randomized, single-dose study assessing the pharmacodynamic parameters of an experimental combination therapy in patients with rheumatoid arthritis on stable methotrexate (MTX) treatment. Birmingham, AL (PRWEB) June 10, 2014 *To see if you qualify for this RA Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance...

2014-06-04 08:31:12

New oral XELJANZ( TM), now available in Canada KIRKLAND, QC, June 4, 2014 /CNW/ - Catherine Hofstetter was diagnosed with rheumatoid arthritis 22 years ago and it changed her life. "My diagnosis felt like a life sentence," says Hofstetter. "Even though I was able to find a treatment to help me manage my symptoms, small, everyday things like buttoning a shirt can still be difficult. New treatments are essential in bringing hope to patients that their disease can be managed."...

2014-06-03 23:02:18

Signature event funds research, programs, support and breakthrough initiatives Toronto, Ont. (PRWEB) June 03, 2014 This Sunday, June 8th marks the single biggest day for arthritis fundraising in Canada. The 5th annual Walk to Fight Arthritis unfolds in over 25 communities coast-to-coast, raising funds and awareness for the country’s leading chronic condition. The Walk unites families, friends and organizations in a common goal of delivering support and solutions for the over 4.6 million...

2014-06-03 12:39:19

Leveraging Nurse Support Could Boost Engagement with Rheumatoid Arthritis Brands, According to Findings in New Manhattan Research Analysis from Decision Resources Group BURLINGTON, Mass., June 3, 2014 /PRNewswire/ -- Manhattan Research's new Digital Competitive Landscape analysis finds that many rheumatoid arthritis (RA) brands are overlooking valuable ways to reach patients and physicians through digital channels and support their evolving needs. Each opportunity represents a risk in a...

2014-05-29 16:26:10

VANCOUVER, May 29, 2014 /PRNewswire/ - Augurex Life Sciences Corp. announces a ground-breaking body of new data that will publish during the European League Against Rheumatism (EULAR) Annual Congress of Rheumatology taking place June 11-14 in Paris. Investigators will present the studies listed in the schedule below, which to date along with other publications, represent over 2000 patients evaluated with the 14-3-3 eta blood test. This follows the very recent publication of a study...

2014-05-28 23:01:14

Colarasis, Inc. now offers Roman’s Pain Rub, a skin balm formulated to relieve pain. Houston, TX (PRWEB) May 28, 2014 In business since May 2010, Colarasis, Inc. is now offering a pain relief rub proven to help the millions of people who suffer from arthritis pain. Colarasis, Inc. of Houston, TX recently formulated Roman’s Pain Rub, an analgesic skin balm that consists of rich and pure emollients, lubricants and penetrating agents. It acts as a numbing sensation which generates to...

2014-05-19 16:22:29

Early diagnosis and treatment can help you maintain an active lifestyle ROSEMONT, Ill., May 19, 2014 /PRNewswire-USNewswire/ -- Suffering with pain or stiffness in your feet and ankles? It could be arthritis. More than 52 million Americans have the condition, which destroys the normal workings of a joint. Arthritis most commonly affects the knees, hands, hips and spine, all of which impact quality of life in some way. But when arthritis affects the feet and ankles, mobility can be...

2014-05-15 08:31:49

Biologic with unique therapeutic approach for OA, which affects over 80 million worldwide CLEVELAND, May 15, 2014 /PRNewswire-USNewswire/ -- NovelMed Therapeutics announced today positive data using its novel, humanized monoclonal antibody in two well-established models of osteoarthritis (OA), characterized by osteophyte formation and cartilage loss. Approximately one in ten people worldwide are affected by OA, with the total number of afflicted patients expected to increase from 75...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related